Connection

Charles Smith to Pancreatic Neoplasms

Back to Details
This is a "connection" page, showing publications Charles Smith has written about Pancreatic Neoplasms.
Charles Smith
Connection Strength
0.411
Pancreatic Neoplasms
  1. Combined anticancer effects of sphingosine kinase inhibitors and sorafenib. Invest New Drugs. 2011 Dec; 29(6):1132-42.
    View in: PubMed
    Score: 0.278
  2. Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640. Oncotarget. 2016 Sep 13; 7(37):60181-60192.
    View in: PubMed
    Score: 0.108
  3. Tissue biomarkers of drug efficacy: case studies using a MALDI-MSI workflow. Bioanalysis. 2015; 7(20):2611-9.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.